Use of in vitro to in vivo extrapolation to predict the optimal strategy for patients switching from efavirenz to maraviroc or nevirapine.
about
Use of in vitro to in vivo extrapolation to predict the optimal strategy for patients switching from efavirenz to maraviroc or nevirapine.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Use of in vitro to in vivo ext ...... nz to maraviroc or nevirapine.
@en
Use of in vitro to in vivo ext ...... nz to maraviroc or nevirapine.
@nl
type
label
Use of in vitro to in vivo ext ...... nz to maraviroc or nevirapine.
@en
Use of in vitro to in vivo ext ...... nz to maraviroc or nevirapine.
@nl
prefLabel
Use of in vitro to in vivo ext ...... nz to maraviroc or nevirapine.
@en
Use of in vitro to in vivo ext ...... nz to maraviroc or nevirapine.
@nl
P2093
P2860
P50
P1476
Use of in vitro to in vivo ext ...... enz to maraviroc or nevirapine
@en
P2093
Alessandro Schipani
David Back
Gerry Davies
P2860
P2888
P304
P356
10.1007/S40262-014-0184-8
P577
2015-01-01T00:00:00Z